Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1871
Peer-review started: January 21, 2022
First decision: February 24, 2022
Revised: February 28, 2022
Accepted: March 27, 2022
Article in press: March 27, 2022
Published online: May 7, 2022
Processing time: 97 Days and 13.1 Hours
Helicobacter pylori (H. pylori) has long been believed to be the major colonizer of the stomach, but recent advances in genetic sequencing have allowed for further differentiation of the gastric microbiome and revealed the true complexity of the gastric microbiome. One of the few studies specifically evaluated the microbiome in the H. pylori negative patient population. They concluded that various stages of gastric carcinogenesis are associated with distinct bacterial taxa that could service both a predictive and diagnostic purpose. While the study has some limitations, the conclusions they make are intriguing and should prompt a larger prospective study to be done that spans multiple geographic regions.
Core Tip: Gastric tumorigenesis in Helicobacter pylori (H. pylori) negative patients remained a mystery for many years until genetic sequencing allowed for a closer look at the composition of the gastric microbiome. Primary colonizers of the stomach in H. pylori negative patients at various stages of gastric tumorigenesis and were able to conclude that there are distinct bacterial taxa associated with these stages. Their study is comprehensive but needs a larger prospective study to further support this hypothesis, particularly in other geographic areas with varying risk profiles.